IMMIOS b.v.

Immios b.v. email format

Verified email-pattern data for Immios B.v. is currently limited. You can still use the company insights and contact sections below.
IIMMIOS is a pre-clinical stage company developing IMS-2407 antibody to reset tissue auto-immune disease providing durable relapse-free benefit to patients suffering from auto-immune and inflammatory disease. Our lead program is set-up to file IND/CTA YE 2026 and deliver proof of mechanism in patients (in two indications) in 2028. Portfolio development is ongoing to identify second program following IMS-2407. #autoimmune disease #antibody development #Series A fundraise #immune reset
Looking for a particular IMMIOS b.v. employee's phone or email?

Immios B.v. Questions

Explore related pages

Related company profiles:

Top IMMIOS b.v. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant